Back to Search
Start Over
O020 Asthma exacerbations and lung function decline in children during a 52-week controlled trial of omalizumab.
- Source :
- Annals of Allergy, Asthma & Immunology; Nov2016 Supplement, Vol. 117, pS7-S8, 1p
- Publication Year :
- 2016
Details
- Language :
- English
- ISSN :
- 10811206
- Volume :
- 117
- Database :
- Supplemental Index
- Journal :
- Annals of Allergy, Asthma & Immunology
- Publication Type :
- Academic Journal
- Accession number :
- 118998801
- Full Text :
- https://doi.org/10.1016/j.anai.2016.09.380